Literature DB >> 14592931

Neuroprotection by tempol in a model of iron-induced oxidative stress in acute ischemic stroke.

Shyamal H Mehta1, R Clinton Webb, Adviye Ergul, Amany Tawfik, Anne M Dorrance, Amany Tawak.   

Abstract

Studies suggest iron exacerbates the damage caused by ischemic stroke. Our aim was to elucidate the effect of iron overload on infarct size after middle cerebral artery occlusion (MCAO) and to evaluate the efficacy of tempol, a superoxide dismutase mimetic, as a neuroprotective agent. Rats were administered iron +/- tempol before MCAO; control rats received saline. The middle cerebral artery was occluded for 24 h, and the size of the resultant infarct was assessed and expressed as the percentage of the hemisphere infracted (%HI). Iron treatment increased infarct size compared with control (51.83 +/- 3.55 vs. 27.56 +/- 3.28%HI iron treated vs. control, P = 0.01); pretreatment with tempol reversed this (51.83 +/- 3.55 vs. 26.09 +/- 9.57%HI iron treated vs. iron + tempol treated, P = 0.02). We hypothesized that reactive oxygen species (ROS) were responsible for the iron-induced damage. We measured ROS generated by exogenous iron in brain and peripheral vasculature from rats that had not undergone MCAO. There was no increase in ROS production in the brain of iron-treated rats or in brain slices incubated with iron citrate. However, ROS generation in carotid arteries incubated with iron citrate was significantly increased. ROS generation from the brain was assessed after MCAO by dihydroethidine staining; there was a dramatic increase in the ROS generation by the brain in the iron-treated rats compared with control 30 min after MCAO. We propose that iron-induced ROS generation in the cerebral vasculature adds to oxidative stress during an ischemic episode after the disruption of the blood-brain barrier.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14592931     DOI: 10.1152/ajpregu.00446.2002

Source DB:  PubMed          Journal:  Am J Physiol Regul Integr Comp Physiol        ISSN: 0363-6119            Impact factor:   3.619


  17 in total

Review 1.  Neurotrophic and neuroprotective actions of estrogen: basic mechanisms and clinical implications.

Authors:  Darrell W Brann; Krishnan Dhandapani; Chandramohan Wakade; Virendra B Mahesh; Mohammad M Khan
Journal:  Steroids       Date:  2007-02-21       Impact factor: 2.668

Review 2.  Hydroethidine- and MitoSOX-derived red fluorescence is not a reliable indicator of intracellular superoxide formation: another inconvenient truth.

Authors:  Jacek Zielonka; B Kalyanaraman
Journal:  Free Radic Biol Med       Date:  2010-01-29       Impact factor: 7.376

3.  Investigating retinal toxicity of tempol in a model of isolated and perfused bovine retina.

Authors:  Kai Januschowski; Sebastian Mueller; Rebecca Dollinger; Sven Schnichels; Johanna Hofmann; Martin S Spitzer; Karl-Ulrich Bartz-Schmidt; Peter Szurman; Sebastian Thaler
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-05-02       Impact factor: 3.117

4.  Iron Oxide Nanoparticles Induce Dopaminergic Damage: In vitro Pathways and In Vivo Imaging Reveals Mechanism of Neuronal Damage.

Authors:  Syed Z Imam; Susan M Lantz-McPeak; Elvis Cuevas; Hector Rosas-Hernandez; Serguei Liachenko; Yongbin Zhang; Sumit Sarkar; Jaivijay Ramu; Bonnie L Robinson; Yvonne Jones; Bobby Gough; Merle G Paule; Syed F Ali; Zbigniew K Binienda
Journal:  Mol Neurobiol       Date:  2015-10       Impact factor: 5.590

Review 5.  Effects of tempol and redox-cycling nitroxides in models of oxidative stress.

Authors:  Christopher S Wilcox
Journal:  Pharmacol Ther       Date:  2010-02-11       Impact factor: 12.310

Review 6.  Neuroprotective potential of cerium oxide nanoparticles for focal cerebral ischemic stroke.

Authors:  Da Zhou; Ting Fang; Lin-Qing Lu; Li Yi
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2016-07-28

Review 7.  Cerebral neovascularization in diabetes: implications for stroke recovery and beyond.

Authors:  Adviye Ergul; Mohammed Abdelsaid; Abdelrahman Y Fouda; Susan C Fagan
Journal:  J Cereb Blood Flow Metab       Date:  2014-02-05       Impact factor: 6.200

8.  Tamoxifen neuroprotection in cerebral ischemia involves attenuation of kinase activation and superoxide production and potentiation of mitochondrial superoxide dismutase.

Authors:  Chandramohan Wakade; Mohammad M Khan; Liesl M De Sevilla; Quan-Guang Zhang; Virendra B Mahesh; Darrell W Brann
Journal:  Endocrinology       Date:  2007-09-27       Impact factor: 4.736

Review 9.  Chemistry and antihypertensive effects of tempol and other nitroxides.

Authors:  Christopher S Wilcox; Adam Pearlman
Journal:  Pharmacol Rev       Date:  2008-12       Impact factor: 25.468

10.  Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases.

Authors:  Douglas B Kell
Journal:  BMC Med Genomics       Date:  2009-01-08       Impact factor: 3.063

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.